Millennium Health appointed Andrew A. Lukowiak as CEO. Lukowiak brings almost 20 years of management experience in molecular diagnostics. Most recently, he was chief operating officer and interim CEO of a commercial stage CLIA laboratory specializing in the combined use of genetics and algorithmic decision support to improve therapeutic outcomes. He previously held positions at GenMark Diagnostics, Hologic, and Third Wave Technologies. He has served in various roles including operations, R&D, quality/regulatory affairs, scientific/clinical affairs, customer service, and reimbursement.